PacBio logo.jpg
PacBio’s New HiFiViral Surveillance Kit Performance is Not Impacted by Omicron Mutations, Delivering Complete SARS-CoV-2 Genomes for All Circulating Variants
December 28, 2021 09:00 ET | Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Dec. 28, 2021 (GLOBE NEWSWIRE) -- PacBio (Nasdaq: PACB), a leading provider of high-quality, highly accurate, long-read sequencing technology, today announced that its new...
PacBio logo.jpg
PacBio and UCLA Health Announce Research Collaboration for Whole Genome Sequencing in Rare Diseases
December 07, 2021 09:00 ET | Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Dec. 07, 2021 (GLOBE NEWSWIRE) -- PacBio (Nasdaq: PACB), a leading provider of high-quality, highly accurate sequencing platforms, and the UCLA Institute for Precision Health and...
PacBio logo.jpg
PacBio Grants Equity Incentive Award to New Employee
December 03, 2021 17:00 ET | Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Dec. 03, 2021 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced that the Compensation Committee...
PacBio logo
PacBio Names Jason Kang as Vice President and General Manager for Asia-Pacific Region
November 30, 2021 09:00 ET | Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Nov. 30, 2021 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB), a leading provider of high-quality, long-read sequencing platforms, welcomes Jason Kang as Vice President and General...
PacBio logo.jpg
PacBio Grants Equity Incentive Award to New Employee
November 19, 2021 17:00 ET | Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Nov. 19, 2021 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced that the Compensation Committee...
PacBio logo.jpg
PacBio and ARUP Laboratories Collaborate in a Study to Improve Rare Disease Diagnosis
November 18, 2021 09:00 ET | Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Nov. 18, 2021 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, and ARUP Laboratories announced today they are...
PacBio logo
PacBio Launches HiFiViral SARS-CoV-2 Kit and Microbial Whole Genome Sequencing Enhancements to Combat Infectious Disease and Strengthen Public Health Response to Pathogen Threats
November 16, 2021 09:00 ET | Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Nov. 16, 2021 (GLOBE NEWSWIRE) -- PacBio (Nasdaq: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced the launch of the HiFiViral...
Pacific Biosciences logo
PacBio to Present at Upcoming Investor Conferences
November 11, 2021 16:05 ET | Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Nov. 11, 2021 (GLOBE NEWSWIRE) -- PacBio announced today that its executives will be speaking at the following investor conferences: Stifel 2021 Virtual Healthcare Conference on...
Pacific Biosciences logo
Prenetics 選擇 PacBio 的 Sequel IIe 為醫療護理建立個人化基因組學
November 04, 2021 05:15 ET | Pacific Biosciences of California, Inc.
加州門洛公園和香港, Nov. 04, 2021 (GLOBE NEWSWIRE) -- PacBio 將向全球領先的基因組學和診斷測試公司 Prenetics Group Limited 提供高品質、高度準確的測序平台。該公司在香港、東南亞和英國增加了更全面的基因篩查服務,包括攜帶者篩查和癌症風險篩查。 Prenetics 行政總裁 Danny Yeung 表示:「隨著 CircleDNA...
Pacific Biosciences logo
PacBio’s Sequel IIe Selected by Prenetics to Build Personalized Genomics for Healthcare
November 03, 2021 20:00 ET | Pacific Biosciences of California, Inc.
MENLO PARK, Calif. and HONG KONG, Nov. 03, 2021 (GLOBE NEWSWIRE) -- PacBio will be providing its high-quality, highly accurate sequencing platforms to Prenetics Group Limited, a leading global...